Kumamoto Y, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Kitagawa R, Igari J, Oguri T, Kosakai N, Yamaguchi K, Kashitani F, Yonezu S, Yamanaka Y, Takaha M, Iori F
Department of Urology, Sapporo Medical University, School of Medicine, Hokkaido, Japan.
Jpn J Antibiot. 1996 May;49(5):465-93.
The frequencies of isolation and susceptibilities to antimicrobial agents were investigated on 567 bacterial strains isolated from patients with urinary tract infections in 10 hospitals during the period of June 1994 to May 1995. Of the above total bacterial isolates, Gram-positive bacteria accounted for 26.8% and a majority of them were Enterococcus faecalis. Gram-negative bacteria accounted for 73.2% and most of them were Escherichia coli. 1. Enterococcus faecalis. Ampicillin (ABPC) and imipenem (IPM) showed the highest activities against E. faecalis isolated from patients with urinary tract infections. The MIC90s of them were 1 microgram/ml. Vancomycin (VCM) was also active with the MIC90 of 2 micrograms/ml. Piperacillin (PIPC) and biapenem (BIPM) were also active with the MIC90s of 4 micrograms/ml and 8 micrograms/ml, respectively. The others were not so active with the MIC90s of 16 micrograms/ml or above. 2. Staphylococcus aureus including MRSA. VCM showed the highest activities against S. aureus isolated from patients with urinary tract infections. Its MIC90 was 1 microgram/ml against both S. aureus and MRSA. Arbekacin (ABK) was also active with the MIC90 of 2 micrograms/ml. The others except minocycline (MINO) were not so active with the MIC90s of 64 micrograms/ml or above. 3. Staphylococcus epidermidis. MINO showed the strongest activity against S. epidermidis isolated from patients with urinary tract infections. Its MIC90 was 0.25 microgram/ml. ABK was also active with the MIC90 of 1 microgram/ml. Cephems were active with the MIC90s of 2 approximately 16 micrograms/ml, but penicillins and quinolones were not so active with the MIC90s and 64 approximately 128 micrograms/ml. 4. Citrobacter freundii. Gentamicin (GM) showed the highest activities against C. freundii isolated from patients with urinary tract infections. Its MIC90 was 1 microgram/ml. IPM was also active with the MIC90 of 2 micrograms/ml. Cefpirome (CPR) and cefozopran (CZOP) were also active with the MIC90s of 4 micrograms/ml and 8 micrograms/ml. The others were not so active with the MIC90s of 32 micrograms/ml or above. 5. Enterobacter cloacae. IPM showed the highest activities against E. cloacae. Its MIC90 was 0.5 microgram/ml. GM and amikacin (AMK), ciprofloxacin (CPFX) and tosulfloxacin (TFLX) were also active with the MIC90s of 4 micrograms/ml. Penicillins and cephems except latamoxef (LMOX), cefmenoxime (CMX), CPR and CZOP showed lower activities with the MIC90s of 256 micrograms/ml or above. 6. Escherichia coli. Most of antimicrobial agents were active against E. coli. CPR, CZOP, IPM, carumonam (CRMN), CPFX and TFLX showed the highest activities against E. coli. The MIC90s of them were 0.125 microgram/ml or below. Cefotiam (CTM), flomoxef (FMOX) CMX, ceftazidime (CAZ), and LMOX were also active with the MIC90s of 0.25 microgram/ml. Penicillins were not so active with the MIC90s of 128 micrograms/ml or above. 7. Klebsiella pneumoniae. CRMN showed the highest activities against K. pneumoniae. Its MIC90 was < or = 0.125 microgram/ml. CZOP was also active with the MIC90 of 0.25 microgram/ml. Penicillins were not so active with the MIC90s of 128 micrograms/ml or above. 8. Proteus mirabilis. P. mirabilis was susceptible to a majority of drugs. CMX, CAZ, LMOX, CRP, cefpodoxime (CPDX), CRMN, CPFX and TFLX showed the highest activities against P. mirabilis isolated from patients with urinary tract infections. The MIC90s of them were 0.125 microgram/ml or below. MINO was not so active with the MIC90 of 128 micrograms/ml. 9. Pseudomonas aeruginosa. Most of the agents were not so active against P. aeruginosa. IPM showed MIC90 of 8 micrograms/ml. The others were not so active with the MIC90s of 16 micrograms/ml or above. CPFX showed MIC50 of 0.5 microgram/ml.
1994年6月至1995年5月期间,对10家医院尿路感染患者分离出的567株细菌进行了抗菌药物的分离频率和敏感性调查。在上述全部细菌分离株中,革兰氏阳性菌占26.8%,其中大多数为粪肠球菌。革兰氏阴性菌占73.2%,其中大多数为大肠杆菌。1. 粪肠球菌。氨苄西林(ABPC)和亚胺培南(IPM)对从尿路感染患者分离出的粪肠球菌显示出最高活性。它们的MIC90均为1微克/毫升。万古霉素(VCM)也有活性,MIC90为2微克/毫升。哌拉西林(PIPC)和美罗培南(BIPM)也有活性,MIC90分别为4微克/毫升和8微克/毫升。其他药物活性不强,MIC90为16微克/毫升或更高。2. 金黄色葡萄球菌包括耐甲氧西林金黄色葡萄球菌(MRSA)。VCM对从尿路感染患者分离出的金黄色葡萄球菌显示出最高活性。其对金黄色葡萄球菌和MRSA的MIC90均为1微克/毫升。阿贝卡星(ABK)也有活性,MIC90为2微克/毫升。除米诺环素(MINO)外,其他药物活性不强,MIC90为64微克/毫升或更高。3. 表皮葡萄球菌。MINO对从尿路感染患者分离出的表皮葡萄球菌显示出最强活性。其MIC90为0.25微克/毫升。ABK也有活性,MIC90为1微克/毫升。头孢菌素类药物活性较强,MIC90为2至16微克/毫升,但青霉素类和喹诺酮类药物活性不强,MIC90为64至128微克/毫升。4. 弗氏柠檬酸杆菌。庆大霉素(GM)对从尿路感染患者分离出的弗氏柠檬酸杆菌显示出最高活性。其MIC90为1微克/毫升。IPM也有活性,MIC90为2微克/毫升。头孢匹罗(CPR)和头孢唑兰(CZOP)也有活性,MIC90分别为4微克/毫升和8微克/毫升。其他药物活性不强,MIC90为32微克/毫升或更高。5. 阴沟肠杆菌。IPM对阴沟肠杆菌显示出最高活性。其MIC90为0.5微克/毫升。GM、阿米卡星(AMK)、环丙沙星(CPFX)和妥舒沙星(TFLX)也有活性,MIC90为4微克/毫升。除拉氧头孢(LMOX)、头孢甲肟(CMX)、CPR和CZOP外,青霉素类和头孢菌素类药物活性较低,MIC90为256微克/毫升或更高。6. 大肠杆菌。大多数抗菌药物对大肠杆菌有活性。CPR、CZOP、IPM、卡芦莫南(CRMN)、CPFX和TFLX对大肠杆菌显示出最高活性。它们的MIC90为0.125微克/毫升或更低。头孢替安(CTM)、氟氧头孢(FMOX)、CMX、头孢他啶(CAZ)和LMOX也有活性,MIC90为0.25微克/毫升。青霉素类药物活性不强,MIC90为128微克/毫升或更高。7. 肺炎克雷伯菌。CRMN对肺炎克雷伯菌显示出最高活性。其MIC90≤0.125微克/毫升。CZOP也有活性,MIC90为0.25微克/毫升。青霉素类药物活性不强,MIC90为128微克/毫升或更高。8. 奇异变形杆菌。奇异变形杆菌对大多数药物敏感。CMX、CAZ、LMOX、CRP、头孢泊肟酯(CPDX)、CRMN、CPFX和TFLX对从尿路感染患者分离出的奇异变形杆菌显示出最高活性。它们的MIC90为0.1